Search results for "SONAR 2025: New emerging risk insights"

Filter search results

Filter overlay

Filter by Source

Filter by Content type

Filter by Research Series

More filters

Filter by Languages

Filter by Topic

Filter by Product or Solution

Filter by Flagship publication

Filter by Location

Filter by Business line

Filter by Life & Health

search results

Showing 2724 search results
  1. Federico Spagnoli Emerging Markets Ecosystems,

    Published date:

    Published by: Swiss Re Group Content Type: Profile

    Federico Spagnoli is the Emerging Markets Ecosystems, Product Head and Regional President of Argentina, Mexico, Chile, Peru and ...

    Go to Federico Spagnoli
  2. Shifting cyber insurance growth into the next gear

    Published date:

    Published by: Swiss Re Group Content Type: Article

    Explore factors and actionable strategies to accelerate growth in the cyber insurance industry amidst evolving market dynamics.

    Go to Shifting cyber insurance growth into the next gear
  3. Compliance Officer - Fraud Risk (Temporary, 80-100%)

    Published date:

    Published by: Swiss Re Group Content Type: Careers

    Location: Bratislava, SK Are you passionate about fighting financial crime and building robust frameworks to protect a global ...

    Go to Compliance Officer - Fraud Risk (Temporary, 80-100%)
  4. Six years at the top

    Published date:

    Published by: Reinsurance Content Type: Blog

    Swiss Re's success story - five years named #1 US Individual Mortality reinsurer. Illustrated expertise, client-first approach, ...

    Go to Six years at the top
  5. Insurance Must Play a Stronger Role in Advancing Sustainable Development

    Published date:

    Published by: Reinsurance Content Type: Blog

    Explore how insurance can boost sustainable development by bridging global protection gaps through innovative public-private ...

    Go to Insurance Must Play a Stronger Role in Advancing Sustainable Development
  6. GLP-1 drugs may reduce mortality by up to 6.4% in the US by 2045

    Published date:

    Published by: Swiss Re Group Content Type: Press Release

    Swiss Re's optimistic scenario estimates GLP-1 drugs could lead to a reduction in cumulative all-cause mortality in the US ...

    Go to GLP-1 drugs may reduce mortality by up to 6.4% in the US by 2045